These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6701736)

  • 41. Regional perfusion with cis-platinum and dacarbazine.
    Aigner K; Hild P; Henneking K; Paul E; Hundeiker M
    Recent Results Cancer Res; 1983; 86():239-45. PubMed ID: 6685902
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of S100 protein and MIA protein as serum marker for malignant melanoma.
    Djukanovic D; Hofmann U; Sucker A; Rittgen W; Schadendorf D
    Anticancer Res; 2000; 20(3B):2203-7. PubMed ID: 10928178
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A phase II trial of isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft tissue sarcoma of the extremity.
    Brady MS; Brown K; Patel A; Fisher C; Marx W
    Ann Surg Oncol; 2006 Aug; 13(8):1123-9. PubMed ID: 16791448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Regional cytostatic perfusion of the extremities in patients with malignant melanoma and soft tissue sarcoma--therapeutic applications and results].
    Eichfeld U; Gläser A; Schneider G; Kraus J; Pauer HJ; Schwarz I
    Zentralbl Chir; 1993; 118(2):63-8. PubMed ID: 7682024
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Perfusion treatment of extremities in malignant melanoma. 9 year experience in 134 patients].
    Nachbur B; von Wattenwyl G; Goldhirsch A
    Helv Chir Acta; 1983 Jan; 49(5):629-32. PubMed ID: 6832996
    [No Abstract]   [Full Text] [Related]  

  • 46. [Perfusion of the extremities in malignant melanoma. Indication, technic and results].
    Nagel K; Junginger T
    Dtsch Med Wochenschr; 1987 Oct; 112(42):1626-9. PubMed ID: 3665750
    [No Abstract]   [Full Text] [Related]  

  • 47. [Extremity perfusion in malignant melanoma].
    Hohenberger W; Meyer T; Göhl J
    Chirurg; 1994 Mar; 65(3):175-85. PubMed ID: 8194401
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolated extremity perfusion with DTIC. An experimental and clinical study.
    Aigner K; Hild P; Breithaupt H; Hundeiker M; Schwemmle K; Henneking K; Illig L; Merker G; Paul E; Brodkorb J; Jungbluth A
    Anticancer Res; 1983; 3(2):87-93. PubMed ID: 6682645
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of variation of drug dosage on disease control and regional toxicity in prophylactic perfusion for Stage I extremity melanoma.
    Mikhail RA; Boddie AW; Ames FC; Zimmerman SO; McBride CM
    J Surg Oncol; 1984 Dec; 27(4):215-8. PubMed ID: 6503295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Isolated hyperthermic extremity perfusion with vindesine, dacarbazine and cisplatin in the treatment of malignant melanomas].
    Aigner KR; Jungbluth A; Link KH; Walther H; Müller H; Schwemmle K; Ringenberg T; Börger G; Ruppel R; Illig L
    Onkologie; 1984 Dec; 7(6):348-53. PubMed ID: 6396562
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Free dermatoplasty in melanoblastomas treated by perfusion chemotherapy].
    Levin AO; Stepanova NS
    Vestn Khir Im I I Grek; 1976 Jun; 116(6):104-7. PubMed ID: 788314
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiple cutaneous melanoma metastases of an extremity resembling Kaposi's sarcoma: use of regional perfusion.
    Lancer HA; Bronstein BR; Sober AJ
    J Dermatol Surg Oncol; 1984 Mar; 10(3):196-9. PubMed ID: 6699257
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regional perfusion for recurrent malignant melanoma of the extremities.
    Schraffordt Koops H; Oldhoff J; van der Ploeg E; Vermey A; Eibergen R
    Am J Surg; 1977 Feb; 133(2):221-4. PubMed ID: 835797
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perfusion chemotherapy in the primary treatment of melanoma of the extremities.
    Soderberg CH; Coleman GV; Meissner GF; Rege VB; Frater SI
    R I Med J; 1970 Mar; 53(3):142-5 passim. PubMed ID: 5264909
    [No Abstract]   [Full Text] [Related]  

  • 55. [Technic of isolated perfusion of the extremities. Experience with 171 cases].
    Aigner K; Schwemmle K
    Langenbecks Arch Chir; 1983; 359(2):113-22. PubMed ID: 6681855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Perfusion. Regional perfusion technique for melanoma of the extremities. A report on experience with conventional treatment and perfusion in 339 cases.
    Clack RL; Stehlin JS
    Arq Patol; 1967 Dec; 39(3):115-26. PubMed ID: 5622930
    [No Abstract]   [Full Text] [Related]  

  • 57. Perfusion chemotherapy for recurrent melanoma of extremity: a progress report.
    Shingleton WW
    Ann Surg; 1969 Jun; 169(6):969-73. PubMed ID: 5770235
    [No Abstract]   [Full Text] [Related]  

  • 58. [Veno-occlusive syndrome with acute liver dystrophy following decarbazine therapy of malignant melanoma (author's transl)].
    Voigt H; Caselitz J; Jänner M
    Klin Wochenschr; 1981 Mar; 59(5):229-36. PubMed ID: 7218735
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Response of localized melanoma to intra-arterial dimethyl triazeno imidazole carboxamide: a case report.
    Savlov ED; Hall TC
    J Surg Oncol; 1970; 2(4):341-7. PubMed ID: 5520849
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment of malignant melanomas with perfusion in extracorporeal circulation].
    Roselló Ochoa E
    Actas Dermosifiliogr; 1970; 61(11):397-9. PubMed ID: 5526740
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.